EVIDENCE has been reported that patients with transient ischemic attacks (TIA) in the carotid territory benefit from treatment with anticoagulant drugs. 1 2i 3 Patients with cerebral infarction are commonly not treated in the same way because of the risk of cerebral hemorrhage. Studies have shown that, in unselected cases, the risks of anticoagulant therapy can exceed the benefits. 4 A careful selection of patients with cerebral infarction seems warranted in order to study the effect of anticoagulant treatment in this patient category. This study describes the outcome in a selected group of patients with cerebral infarction or TIA in the part of the brain supplied by the carotid artery. All patients were investigated by cerebral angiography and were followed during and after anticoagulant therapy.
Materials and Methods

Patients
One hundred sixty-two consecutive patients, 47 females and 115 males, 36 patients with TIA, and 126 with cerebral infarction were included. The age distribution is given in table 1. In patients with cerebral infarction, neurological signs and symptoms had perFrom the Departments of Neurology (Drs. Link and Lebram) and Radiology (Drs. Johansson and Radberg), University Hospital, S-581 85 Linkoping, Sweden sisted for more than 24 h, and the neurological examination usually revealed persistent, though often only slightly disabling, symptoms. TIA was defined as an attack with symptoms and signs of neurological dysfunction of less than 24 h duration. The patients were admitted to the neurology department during a 2 year period (Oct. 1, 1973 1, to Sept. 30, 1975 . Only those patients were included who were considered candidates for carotid endarterectomy and/or anticoagulant treatment, i.e. the biological age was acceptably low, the patients were considered able to manage treatment with anticoagulants, and they were not living too far from facilities for control of treatment. Patients with disorders which contraindicated anticoagulant therapy were excluded. High blood pressure was not considered a contraindication, but was always lowered to a value below 160/100 mm Hg before anticoagulant therapy was started. Electrocardiograms and determinations of serum transaminases were performed in all 162 patients on day 1 and 3 after admission. Patients with a probable source of embolism other than the carotid artery or its branches were excluded. These included patients with recent myocardial infarction or artrial fibrillation. CSF studies and cerebral angiography was carried out in all patients.
CSF Investigations
In all patients lumbar puncture was performed on admission and repeated on day 3 after development of symptoms; also immediately prior to institution of anticoagulant therapy. Echoencephalography was also performed. CSF total and differential cell counts were made by phase contrast microscopy according to Sornas, 5 and absorbancy of the centrifuged fluid was measured at 415 nm in order to exclude hematoma or hemorrhagic infarction. Only patients with colorless CSF, absorbancy at 415 ^ 0.050 nm, and without a significant polymorphonuclear neutrophilic leukocytereaction 6 were considered candidates for anticoagulant therapy.
Angiography
Angiography was performed on all 162 patients, in most cases by direct puncture of the common carotid artery (CCA) low in the neck on the symptomatic side whereupon a catheter was introduced. Precautions were taken not to enter the internal carotid artery (ICA) with the guide wire or the catheter. In those patients where CCA angiography revealed an operable atherosclerotic lesion in the extracranial portion of the ICA, preoperative aortic arch angiography was also carried out. Operation by carotid endarterectomy was considered when the clinical findings and angiography made it appear most likely that the cerebral hemispheric symptoms were due to embolism from an atherosclerotic lesion within extracranial portion of the ICA or due to severe stenosis of this part of the vessel probably influencing cerebral blood flow on the same side. In 69 patients only CCA angiography was performed, in 20 patients only aortic arch angiography, and in the remaining 73 patients both investigations were done.
Angiography revealed occlusion of the ICA on the relevant side in 10.5% of the patients (table 2), nonocclusive atherosclerotic lesions within the territory of the ICA on the relevant side in 82%, and a normal angiogram on the relvant side in the remaining 7.5%. Subdivision of the patients according to localization of the angiographically verified atherosclerotic lesions (table 2) revealed a predominance of lesions either in the extracranial or intracranial part of the ICA territory in the patients with TIA. Only 5.6% of the TIA patients had extracranial as well as intracranial atherosclerosis in the ICA on the relevant side, compared to 31.8% of the patients with cerebral infarction (p <0.01; chi-square test).
No complications of angiography were encountered in the 162 patients.
Anticoagulant Treatment
In the TIA patients, anticoagulant treatment usually was begun immediately after the diagnosis. In most of the patients with cerebral infarction, anticoagulant treatment was started after angiography had been carried out, (usually 2-4 days after admission). When cerebral angiography was performed after anticoagulant therapy had been started, the Trombotest values, using the method of Owren (TT values), were in the upper region (10-15%) of the therapeutic range (5-15%).
Usually anticoagulant treatment was started with a combination of heparin given intravenously (10,000 and 12,000 IU alternately every 6 hours) and dicoumarol until the TT values were below 20%. Then heparin was discontinued. Treatment was considered to be effective when the TT values were below 15%. Solitary values between 15-20% were accepted as adequate. When the TT values were above these limits, the patients were considered as inadequately treated. Anticoagulation regulation was carried out by one experienced physician for all patients and all were treated in the outpatient department.
Results
The principal modes of treatment in the patients are summarized in table 3. Seventy-six of the patients were treated with anticoagulants. In 41 additional patients anticoagulant treatment was given until carotid endarterectomy was performed. In the remaining 45 patients neither of these forms of treatment was given. Seventeen patients were not treated with anticoagulants because angiography revealed occlusion of the internal carotid artery, and in 12 patients no treatment was given because angiography did not show any relevant source of embolism. In the remaining 16 patients anticoagulants were not given because additional data were obtained which made this therapy less desirable, e.g. reduced mental facility, difficulties in treatment control and disease which contraindicated treatment.
Course During Anticoagulant Treatment
The observation time of anticoagulant treatment was 1,298 months in 117 patients (mean 11.1 months). The mean observation time in the patients with TIA and with cerebral infarction was similar (table 4) .
None of the 31 patients with TIA developed a cerebral infarction during treatment. Among the 86 patients with cerebral infarction, 1 patient developed another infarction within the same vascular territory. This patient did not get heparin, and a definite infarction with total hemiplegia appeared on the second day when the TT value was 39%, which was considered inadequate anticoagulation. No TIA was reported by the 117 patients during anticoagulant treatment.
Complications due to this treatment were observed in 10 of the 117 patients and consisted of various types of bleeding, e.g., epistaxis, hemoptysis and hematoma. Six of the patients had to discontinue treatment because of these complications. No intracranial bleedings or irreversible lesions were observed.
Course after Cessation of Anticoagulants or During Inadequate Anticoagulant Treatment
Of the 117 patients who were treated by anticoagulants, 41 had a carotid endarterectomy. These The remaining 76 patients were treated with anticoagulants and observed after cessation of treatment, which was discontinued after 1 year. The observation period after cessation of anticoagulant therapy in these 76 patients was 331 months (4.4 months per patient) (table 5) . During this period, 10 of the patients developed cerebral infarction. Only one cerebral infarction occurred among the 20 patients with TIA, and the remaining 9 occurred in the 56 patients with an initial cerebral infarction. The difference between appearance of cerebral infarction in the 117 patients during anticoagulant treatment, and in the 76 patients after cessation of this treatment was statistically significant (p<0.001; Fisher's exact test).
Course in Untreated Patients
Forty-five of the patients did not receive anticoagulant treatment or vascular surgery (table 3). In 17 of them, angiography showed occlusion of the ICA on the relevant side. These patients were not further followed in this study. Among the remaining 28 patients, 12 were not treated because angiography did not reveal any atherosclerotic lesion within the territory of the ICA on the relevant side. The mean observation time in these 12 patients was 16.5 months. One of these patients, who initially had a cerebral infarction, developed another infarction within the same vascular territory and became institutionalized.
Sixteen patients did not receive any form of treatment because contraindications were found when carotid angiography was performed. The mean observation period in these 16 patients was 25.9 months. Five of these patients developed cerebral infarction and 4 had to be institutionalized.
Deaths
Two patients previously treated with anticoagulants died, one from cerebral infarction and the other from myocardial infarction. Of the untreated patients with TIA, 1 died of myocardial infarction, and among the untreated patients with cerebral infarction 1 died of stroke, 3 of myocardial infarction, and 3 of other causes. 
Discussion
We have selected a group of patients with transitory or persistent neurologic dysfunction due to ischemia in the carotid territory, who might benefit from anticoagulant treatment. In order to establish the diagnosis and rule out disorders which may simulate TIA or cerebral infarction and to identify those patients who would benefit from carotid endarterectomy, angiography was carried out in all patients. The absence of complications from angiography in these selected patients is consistent with the low complication rate reported from Sweden at other centers. Computerized tomography was not available during the present study.
At angiography, all of our patients had at least 2 views of the neck vessels to establish whether atherosclerosis existed. A remarkably high incidence of abnormal angiograms was found, due to atherosclerosis of the ICA and/or its branches. Of the patients, 92.5% showed abnormalities varying from minor atherosclerotic plaques without ulceration or stenosis, to carotid occlusions. As the angiograms were undertaken mainly to demonstrate extracranial stenosis, minor intracranial atherosclerotic plaques may have been missed in some patients. In previous studies, higher frequencies of normal angiograms have been reported. 3 ' 7 Treatment with anticoagulants was considered indicated in 117 of the 162 patients after a clinical study ruled out any other cause for the symptoms, and angiography had shown atherosclerotic plaques which could be a source of microembolism in patients with TIA or of embolism in patients with infarction. Treatment with anticoagulants was not given to patients with occlusion of the ICA on the relevant side, nor to those where angiography did not reveal any atherosclerotic lesion within the ICA on the relevant side. Contraindications against anticoagulant treatment were carefully and consistently considered in each patient. Blood pressure was examined at 3-4 month intervals and hypertension was vigorously treated.
None of the patients had a TIA or cerebral infarction during the treatment period. One patient developed an infarction with severe disability before adequate anticoagulation. Anticoagulant treatment was started with dicoumarol and heparin simultaneously in all but 5 of the patients. Our impressions are in accordance with the suggestions by Toole et-al. 8 that it is wise to start treatment with a fast-acting anticoagulant. Side effects of the treatment during a mean observation time of 11.1 months occurred in 10 of 117 patients (8.6%), and side effects necessitating withdrawal of treatment occurred in 6 of them (5.1%). None of the patients died during therapy.
The high number of subsequent cerebral infarction after discontinuance of anticoagulant treatment is remarkable. One of the 20 patients with TIA developed an infarction during a mean observation period of 3.6 months. This incidence corresponds well with the results from other studies. Nine of the 56 patients with previous cerebral infarction (16%) had a recurrent cerebral infarction in the same vascular territory during a mean observation time of 4.6 months. Whisnant et al. found that the first year recurrence rate of stroke (including infarction, hemorrhage and subarachnoid bleeding) in an untreated population was 10%. 9 When analyzing a clearly defined group of TIA and infarctions termed TIA-IR (incomplete recovery) Olsson et al. found a recurrence rate of 13% in the first year. 3 There is no obvious explanation for our high recurrence rate. It must be noted that no other treatment, e.g. for hypertension or cardiac disease, was changed when anticoagulant treatment was withdrawn. Our figures show that the risk of developing a new infarction in patients with previous cerebral infarction does not diminish after 1 year of treatment. Among the patients with recurrent strokes, only 1 of the 9 had to be institutionalized, while the remaining 8 patients were again treated with anticoagulants, their treatment time being included in this study.
Among the 16 patients with TIA or infarction who had relevant lesions on angiography but were not treated because new evidence had accumulated which made anticoagulant therapy less desirable, 5 (31%) had subsequent strokes during a mean observation time of 25.9 months. Comparison with the treated group is inadequate because new circumstances might have influenced the course of their disease.
Although the patient groups were not of the same size, the present results indicate that anticoagulants seem to be of value in TIA and also in cerebral infarction in brain areas supplied by the carotid artery.
